361 CAPITAL LLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 273 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
361 CAPITAL LLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2020$1,074,000
-13.2%
18,555
-19.2%
0.49%
+42.3%
Q4 2019$1,238,000
+2.6%
22,956
-3.9%
0.34%
+63.3%
Q1 2019$1,207,000
-21.8%
23,895
-21.8%
0.21%
-40.0%
Q2 2018$1,543,000
-0.8%
30,556
+3.4%
0.35%
-9.1%
Q1 2018$1,556,000
-36.4%
29,547
-43.9%
0.38%
-36.5%
Q4 2017$2,447,000
+1105.4%
52,662
+948.0%
0.61%
+1453.8%
Q3 2017$203,0005,0250.04%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Zebra Capital Management LLC 20,591$895,0001.43%
Global Alpha Capital Management Ltd. 330,270$14,357,0001.39%
AIMZ Investment Advisors, LLC 73,875$3,211,0001.25%
Hillcrest Asset Management LLC 184,010$7,999,0001.22%
Bridge City Capital, LLC 56,869$2,472,0001.02%
SNYDER CAPITAL MANAGEMENT L P 683,700$29,720,0000.72%
EARNEST PARTNERS LLC 2,188,606$95,139,0000.55%
RICE HALL JAMES & ASSOCIATES, LLC 343,347$14,925,0000.53%
PALISADE CAPITAL MANAGEMENT, LP 584,957$25,428,0000.52%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 45,693$1,986,0000.45%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders